CSS
LXEO icon

Cubist Systematic Strategies’s Lexeo Therapeutics LXEO Stock Holding History

Cubist Systematic Strategies’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.6K Buy
+2,506
New +$12.1K ﹤0.01% 2908
2025
Q1 		– Sell
-1,726
Closed -$11.4K – 3222
2024
Q4 		$11.4K Buy
+1,726
New +$13.6K ﹤0.01% 2856
2024
Q1 		– Sell
-25,750
Closed -$346K – 4056
2023
Q4 		$346K Buy
+25,750
New +$320K ﹤0.01% 2722

Other funds holding LXEO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's LXEO Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Lexeo Therapeutics (LXEO) in Q3 2025: 2,506 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #2908 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in LXEO as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in LXEO in Q4 2023 and has held it in 3 quarters since. The position peaked at $346K in Q4 2023. 109 funds tracked by Wall St. Rank hold LXEO as of Q3 2025.

  • Cubist Systematic Strategies held 2,506 shares of Lexeo Therapeutics worth $16.6K as of Q3 2025.
  • Lexeo Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Lexeo Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2908 holding.
  • Cubist Systematic Strategies first reported a position in Lexeo Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Cubist Systematic Strategies's Lexeo Therapeutics position peaked at $346K in Q4 2023.
  • 109 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.